about
Prophylaxis for venous thromboembolism during treatment for cancer: questionnaire surveyWhen are breast cancer patients at highest risk of venous thromboembolism? A cohort study using English health care data.Challenges in enumeration of CTCs in breast cancer using techniques independent of cytokeratin expression.Tissue Factor promotes breast cancer stem cell activity in vitro.The use of isotope injections in sentinel node biopsy for breast cancer: are the 1- and 2-day protocols equally effective?Increased peri-ductal collagen micro-organization may contribute to raised mammographic density.Early changes in the haemostatic and procoagulant systems after chemotherapy for breast cancerPatient-derived Mammosphere and Xenograft Tumour Initiation Correlates with Progression to Metastasis.Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.The significance of circulating tumour cells in breast cancer: a review.Infection prevention in breast implant surgery - A review of the surgical evidence, guidelines and a checklist.Improving accuracy of clinical coding in surgery: collaboration is key.Tumour bed clip localisation for targeted breast radiotherapy: compliance is proportional to trial-related research activity: tumour bed clip localisation in breast radiotherapy.Breast cancer screening: what does the future hold?National survey of breast cancer specimen orientation marking systems.Letter to the editor regarding manuscript entitled: completion axillary dissection can safely be omitted in screen detected breast cancer patients with micrometastases. A decade's experience from a single institution. Grabau D, Dihge L, Ferno M, IngPrepectoral Implant-Based Breast Reconstruction.Venous thromboembolism and mortality in breast cancer: cohort study with systematic review and meta-analysis.Immediate breast reconstruction does not increase postmastectomy pain.Colorectal cancer and thrombosis.Results from the BRIOS randomised trial.Reply to: Letter Infection prevention in breast implant surgery - A review of the surgical evidence, guidelines and a checklist.Orbital metastases as the primary presentation of lobular breast cancer.Reply to: Impact of laminar air flow on operating room contamination and surgical wound infection rates in clean and contaminated surgery.Effect of Tissue Factor on Colorectal Cancer Stem CellsIt's PRIMETIME. Postoperative Avoidance of Radiotherapy: Biomarker Selection of Women at Very Low Risk of Local RecurrenceCurrent UK practice of thromboprophylaxis for breast surgeryVascular endothelial growth factor-C in patients with breast cancerAngiogenic characteristics of circulating and tumoural thrombospondin-1 in breast cancerAlteration in platelet function in patients with early breast cancerIncidence of venous thromboembolism during chemotherapy for breast cancer: impact on cancer outcomeCurrent attitudes to breast reconstruction surgery for women at risk of post-mastectomy radiotherapy: A survey of UK breast surgeonsInvestigation of proposed mechanisms of chemotherapy-induced venous thromboembolism: endothelial cell activation and procoagulant release due to apoptosisComparing long-term local recurrence rates of surgical and non-surgical management of close anterior margins in breast conserving surgeryIs breast seroma after tumour resection associated with patient-reported breast appearance change following radiotherapy? Results from the IMPORT HIGH (CRUK/06/003) trialPatient-Reported Outcomes Over 5 Years After Whole- or Partial-Breast Radiotherapy: Longitudinal Analysis of the IMPORT LOW (CRUK/06/003) Phase III Randomized Controlled TrialA randomized, window of opportunity study comparing the effects of the novel oral SERD AZD9496 with fulvestrant in patients with ER+ HER2- primary breast cancerClinical management of idiopathic mastalgia: a systematic reviewBreast cancer stromal clotting activation (Tissue Factor and thrombin): A pre-invasive phenomena that is prognostic in invasionCirculating tumour cells and hypercoagulability: a lethal relationship in metastatic breast cancer
P50
Q28165290-39E8F665-4C9A-4A68-A87D-6D7913798D10Q31024426-490D8107-41D6-4220-BF31-07014CDF911DQ33579810-74CA1EE0-5F33-43D4-B623-3BFD0EA35373Q33688466-6A0223F1-F063-4A44-AB4D-401084489DB5Q36062941-741865F5-89D4-4F1F-BA15-95A824A80BB8Q36446246-A40B3391-F7D9-4572-8010-721481AFF061Q36936061-8B394043-2036-42C1-BF53-A52338A0E2ABQ37507350-7B3E03B7-C276-4BB9-80E3-01A0BB7D788CQ37533025-941BCB3F-0809-4A5B-A0C6-E59C096C28A8Q38239983-7EC06086-58CC-4D34-96D0-6E572F804820Q38785702-FCB0DC66-31A0-4566-8BB9-1F387740A620Q39450458-102621FE-30BA-429E-AF42-46F829C259EFQ43624087-7C2DEF56-B3AF-4E42-841B-3F049DD30441Q44296250-B15276BE-6B96-4373-9D41-E2C9CC1029E9Q45731053-C669759A-4211-4E1C-B4AD-43BB2E6E9405Q46771010-6C68C5DE-8564-438B-9DE7-F1B68AB0525FQ47132402-587B4563-8CDF-4562-AB83-A7DA4EA0CE04Q47616727-781460F7-0FFD-4053-8D27-DA8FC335DFD5Q47700509-9EF2E036-CAB6-4A5B-8E14-2C1F4E701E80Q47845649-2E7BEE5A-FC00-4DC5-A677-3863E921A55DQ47930133-1F9AC81B-743A-4575-AFD6-23672EE5EFAFQ51283451-F1D150AD-AB33-47C7-BE79-6AE86A77E0C8Q53115455-ED764FC1-FF09-4F43-A45C-F721B839E9A2Q54504861-0A3B546D-8C34-4BA3-B81A-5484FA8403FDQ59349078-F11786EF-F216-4563-9EC7-37DDA050C792Q59487374-0CDEA862-0F44-4DF9-9B95-7F2EE9C23DE8Q79969496-9E3A81F4-22A8-46DB-9D02-8F4EDDA31746Q80526385-F55B816D-1A04-447F-8BDF-493BED1ABB99Q81388209-8BE235DD-5592-4B58-BB62-2F80F5F7A1E1Q81533529-B6586962-AED4-4C67-9248-F5216AD97652Q84519537-DD5F74A8-F04C-4D83-B203-B62A7F8D4F9DQ85233583-098B3EF7-49A6-4C1C-9703-D3C16CAE8930Q86882874-1D0EF3CC-A0CC-423D-A8E0-AFE2C4944A5EQ90221040-E107C363-1A8B-4E76-A53C-5F0701858B57Q90249505-B1A5098B-A7FD-479F-B766-AC56848557B5Q90378928-A156C529-5CAE-4F91-A1AF-2E10F5DB0057Q90802186-083BB090-1F32-4A87-922E-CF9203525AF9Q91649406-55013780-032E-4B52-9D31-4E279E2DCEECQ92803243-AE3FCADD-25E6-4DA3-8092-6DDFB1DAB22FQ93040699-B243D2F3-C634-47C1-9229-FACE5EE6EC34
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0002-1725-4790
@en
name
Cliona C Kirwan
@ast
Cliona C Kirwan
@en
Cliona C Kirwan
@es
Cliona C Kirwan
@nl
type
label
Cliona C Kirwan
@ast
Cliona C Kirwan
@en
Cliona C Kirwan
@es
Cliona C Kirwan
@nl
prefLabel
Cliona C Kirwan
@ast
Cliona C Kirwan
@en
Cliona C Kirwan
@es
Cliona C Kirwan
@nl
P106
P1153
56653276800
9337630100
P31
P496
0000-0002-1725-4790